Navigation Links
New England Pediatric Device Consortium Awards Velano Vascular in Support of Needle Free Blood Draw Technology
Date:3/24/2017

LEBANON, N.H., March 24, 2017 /PRNewswire-USNewswire/ -- New England Pediatric Device Consortium (NEPDC) announced Velano Vascular as the recipient of an award including funding and in-kind service towards the commercialization of the company's needle free blood draw technology. 

"Making blood draws less traumatic for children could go a long way to making their whole hospital experience better.  We're looking forward to working with Velano Vascular to see how this technology can help improve care for the kids we treat," said Ann-Christine Duhaime, MD, NEPDC Co-Director and Director of the Pediatric Neurosurgery Department at Massachusetts General Hospital.

After a successful early engagement with Velano Vascular and their product, PIVO™, an FDA cleared device that makes inpatient blood draws a seamless and stress-free experience by reducing the number of sticks for blood collection, NEPDC will continue to support Velano Vascular in their efforts to engineer the device for use in smaller children and infants.

"We are honored to act as collaborators with NEPDC and the FDA in pursuit of a shared vision to eliminate the pain and anxiety that kids so closely associate with this necessary medical procedure," said Velano Vascular CEO Eric M. Stone. "With PIVO, pediatric blood draws can become a less stressful, more pleasant experience for both children and their parents."

NEPDC offers commercialization resources for pediatric medical devices through a seed grant program made possible through funds from the FDA Office of Orphan Product Development.         

About New England Pediatric Device Consortium (NEPDC)

NEPDC is a non-profit consortium that provides infrastructure, expert consultation to innovators, and execution of technology translation and commercialization of pediatric technologies.  For further information, visit www.NEPDC.org.

About Velano Vascular

Velano Vascular is committed to reducing the pain, risk, and inefficiencies of vascular access and blood collection practices. Velano Vascular's PIVO device enables blood draws from Peripheral IV catheters, aiming to enable more compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. Velano Vascular is backed by First Round Capital, Griffin Hospital, Kapor Capital, Safeguard Scientifics, Sutter Health, The Children's Hospital of Philadelphia (CHOP), White Owl Capital, and a number of health-industry veterans.  Company collaborators include several of the leading hospital systems in the United States. More information is available at www.velanovascular.com and @velanovascular.

CONTACT: Cassie Brugger, 603-678-8260, cbrugger@nepdc.org

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-england-pediatric-device-consortium-awards-velano-vascular-in-support-of-needle-free-blood-draw-technology-300429055.html


'/>"/>
SOURCE New England Pediatric Device Consortium
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
2. Een studie in het New England Journal of Medicine bevestigt dat universele dekolonisatie van ic-patiënten voor 44% minder bloedstroominfecties zorgt
3. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
4. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
5. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
6. CVS Caremark Uses Data to Combat National Prescription Drug Abuse Epidemic; Program Details Published in New England Journal of Medicine Online
7. New England Laser Options Adds On Professional Hair Removal with the Astanza Liberty IPL System
8. New England Journal of Medicine releases study showing GSKs FluLaval Quadrivalent vaccine effective in preventing seasonal flu in children
9. Romosozumab Phase 2 Data Published In New England Journal Of Medicine Show Significant Increases In Bone Mineral Density At Both Spine And Hip
10. Lyophilization Services of New England Completes FDA Inspection
11. New England Journal of Medicine Study Finds Upper-Airway Electronic Stimulation Effective for Obstructive Sleep Apnea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/19/2017)... April 19, 2017 Cardiology devices segment is anticipated ... The Cardiology Devices segment is likely to create ... Mn in 2018 over 2017. By the end of 2027, ... close to US$ 700 Mn, expanding at a CAGR of ... the Asia Pacific reprocessed medical devices ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and which He does not. Yisrayl says with so many titles and names for ... but he says with a little Scripture, backed with a lot of research, the truth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is ... Côté has 20+ years of experience within the beauty industry, ranging from marketing, ... array of high-end cosmetic brands, retail brands and outlets in Canada and New ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch ... a moisturizer with the power of an anti-aging concentrate. , Anogeissus ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
Breaking Medicine News(10 mins):